Rank | Gene Set | Z-score |
---|---|---|
1 | DNA deamination (GO:0045006) | 5.62305311 |
2 | ribosomal small subunit assembly (GO:0000028) | 5.21897658 |
3 | nucleobase biosynthetic process (GO:0046112) | 4.90099192 |
4 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.85049114 |
5 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.78719826 |
6 | proteasome assembly (GO:0043248) | 4.74556952 |
7 | purine nucleobase biosynthetic process (GO:0009113) | 4.72160320 |
8 | DNA strand elongation (GO:0022616) | 4.60289779 |
9 | formation of translation preinitiation complex (GO:0001731) | 4.44419286 |
10 | maturation of SSU-rRNA (GO:0030490) | 4.39788450 |
11 | DNA replication initiation (GO:0006270) | 4.25232600 |
12 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.23314189 |
13 | IMP biosynthetic process (GO:0006188) | 4.19393029 |
14 | protein maturation by protein folding (GO:0022417) | 4.13152400 |
15 | ribosomal large subunit biogenesis (GO:0042273) | 4.11635536 |
16 | viral transcription (GO:0019083) | 4.10188025 |
17 | telomere maintenance via recombination (GO:0000722) | 4.07607660 |
18 | translational termination (GO:0006415) | 4.04005805 |
19 | DNA replication checkpoint (GO:0000076) | 4.03710173 |
20 | ribosomal small subunit biogenesis (GO:0042274) | 3.96936987 |
21 | pseudouridine synthesis (GO:0001522) | 3.93468917 |
22 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.92719471 |
23 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.88343833 |
24 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.87007699 |
25 | cotranslational protein targeting to membrane (GO:0006613) | 3.83338906 |
26 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.83009452 |
27 | ribosome biogenesis (GO:0042254) | 3.79705467 |
28 | translational elongation (GO:0006414) | 3.78286717 |
29 | protein targeting to ER (GO:0045047) | 3.78032318 |
30 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.76192411 |
31 | termination of RNA polymerase III transcription (GO:0006386) | 3.76192411 |
32 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.71465506 |
33 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.71123740 |
34 | telomere maintenance via telomere lengthening (GO:0010833) | 3.70710740 |
35 | spliceosomal snRNP assembly (GO:0000387) | 3.70313660 |
36 | mitotic recombination (GO:0006312) | 3.70188565 |
37 | translational initiation (GO:0006413) | 3.69198284 |
38 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.68108591 |
39 | protein localization to endoplasmic reticulum (GO:0070972) | 3.66296576 |
40 | protein deneddylation (GO:0000338) | 3.65910127 |
41 | rRNA modification (GO:0000154) | 3.63818730 |
42 | cullin deneddylation (GO:0010388) | 3.63369798 |
43 | IMP metabolic process (GO:0046040) | 3.62180235 |
44 | DNA unwinding involved in DNA replication (GO:0006268) | 3.60053767 |
45 | negative regulation of ligase activity (GO:0051352) | 3.59440410 |
46 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.59440410 |
47 | rRNA processing (GO:0006364) | 3.59264216 |
48 | amino acid salvage (GO:0043102) | 3.58140467 |
49 | L-methionine salvage (GO:0071267) | 3.58140467 |
50 | L-methionine biosynthetic process (GO:0071265) | 3.58140467 |
51 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.57787242 |
52 | translation (GO:0006412) | 3.56851138 |
53 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.56062106 |
54 | ribosome assembly (GO:0042255) | 3.55117646 |
55 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.52979366 |
56 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.52846693 |
57 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.52232879 |
58 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.50274780 |
59 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.50274780 |
60 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.47667855 |
61 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.47667855 |
62 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.47667855 |
63 | CENP-A containing nucleosome assembly (GO:0034080) | 3.46544275 |
64 | establishment of integrated proviral latency (GO:0075713) | 3.46341587 |
65 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.45763190 |
66 | ATP synthesis coupled proton transport (GO:0015986) | 3.45763190 |
67 | cellular component biogenesis (GO:0044085) | 3.44937561 |
68 | rRNA metabolic process (GO:0016072) | 3.42733732 |
69 | protein targeting to mitochondrion (GO:0006626) | 3.39508329 |
70 | chaperone-mediated protein transport (GO:0072321) | 3.39404079 |
71 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.38324893 |
72 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.38324893 |
73 | NADH dehydrogenase complex assembly (GO:0010257) | 3.38324893 |
74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.36683271 |
75 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.36590617 |
76 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.36590617 |
77 | 7-methylguanosine mRNA capping (GO:0006370) | 3.35019113 |
78 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.31793203 |
79 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.31432431 |
80 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.30446094 |
81 | 7-methylguanosine RNA capping (GO:0009452) | 3.29977811 |
82 | RNA capping (GO:0036260) | 3.29977811 |
83 | chromatin remodeling at centromere (GO:0031055) | 3.29908743 |
84 | GDP-mannose metabolic process (GO:0019673) | 3.27481504 |
85 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.24356779 |
86 | cell cycle G1/S phase transition (GO:0044843) | 3.24356779 |
87 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.23565125 |
88 | viral life cycle (GO:0019058) | 3.22487902 |
89 | regulation of mitochondrial translation (GO:0070129) | 3.22011937 |
90 | cellular protein complex disassembly (GO:0043624) | 3.21353065 |
91 | rRNA methylation (GO:0031167) | 3.20703934 |
92 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.20595760 |
93 | oxidative phosphorylation (GO:0006119) | 3.19809637 |
94 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.19419830 |
95 | proline biosynthetic process (GO:0006561) | 3.18685993 |
96 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.17577546 |
97 | transcription from RNA polymerase I promoter (GO:0006360) | 3.16836350 |
98 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.15673714 |
99 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.14495413 |
100 | mitotic metaphase plate congression (GO:0007080) | 3.13169447 |
101 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.13102728 |
102 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.12902528 |
103 | maturation of 5.8S rRNA (GO:0000460) | 3.12831608 |
104 | positive regulation of ligase activity (GO:0051351) | 3.11683619 |
105 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.10958946 |
106 | spliceosomal complex assembly (GO:0000245) | 3.06189068 |
107 | establishment of protein localization to mitochondrion (GO:0072655) | 3.03783188 |
108 | regulation of ligase activity (GO:0051340) | 3.03047935 |
109 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.03004693 |
110 | mitotic nuclear envelope disassembly (GO:0007077) | 3.02607414 |
111 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.01649548 |
112 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.01649548 |
113 | L-serine metabolic process (GO:0006563) | 3.01530083 |
114 | folic acid metabolic process (GO:0046655) | 3.00274300 |
115 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.00190291 |
116 | tRNA methylation (GO:0030488) | 3.00164775 |
117 | termination of RNA polymerase I transcription (GO:0006363) | 3.00000270 |
118 | regulation of cellular amine metabolic process (GO:0033238) | 2.99540275 |
119 | establishment of viral latency (GO:0019043) | 2.99057594 |
120 | respiratory electron transport chain (GO:0022904) | 2.98747937 |
121 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.97741233 |
122 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.94423582 |
123 | protein localization to mitochondrion (GO:0070585) | 2.94328847 |
124 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.91484793 |
125 | electron transport chain (GO:0022900) | 2.91310723 |
126 | peptidyl-histidine modification (GO:0018202) | 2.89620228 |
127 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.87366203 |
128 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.86263166 |
129 | regulation of translational fidelity (GO:0006450) | 2.85389033 |
130 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.85021174 |
131 | transcription from mitochondrial promoter (GO:0006390) | 2.84957405 |
132 | tRNA aminoacylation for protein translation (GO:0006418) | 2.82441481 |
133 | positive regulation of cell cycle arrest (GO:0071158) | 2.81038304 |
134 | purine nucleotide salvage (GO:0032261) | 2.80976050 |
135 | nuclear envelope reassembly (GO:0031468) | 2.79109711 |
136 | mitotic nuclear envelope reassembly (GO:0007084) | 2.79109711 |
137 | negative regulation of protein ubiquitination (GO:0031397) | 2.78975267 |
138 | protein complex biogenesis (GO:0070271) | 2.76978801 |
139 | amino acid activation (GO:0043038) | 2.76827018 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.47042905 |
2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.49685921 |
3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.30643312 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.23595801 |
5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.72023959 |
6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.71834262 |
7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.65779588 |
8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.38811259 |
9 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.27607869 |
10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.15804622 |
11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.13852101 |
12 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.98141130 |
13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.96406189 |
14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.95383011 |
15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.87158485 |
16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.65879248 |
17 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.55486276 |
18 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.50499720 |
19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.49902399 |
20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.45375837 |
21 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.41667018 |
22 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.35343889 |
23 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.33515133 |
24 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.33487029 |
25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.25292286 |
26 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.23607030 |
27 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.22870390 |
28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.22006405 |
29 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.17003995 |
30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.14890951 |
31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.14183650 |
32 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.11552030 |
33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.00649088 |
34 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.98095670 |
35 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.96798104 |
36 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.93666697 |
37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.86523206 |
38 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85141363 |
39 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.85120511 |
40 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.84797678 |
41 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.76892584 |
42 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.75354988 |
43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.72503191 |
44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70572795 |
45 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.70458331 |
46 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.69638832 |
47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.65986091 |
48 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.63876710 |
49 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.60645039 |
50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60243073 |
51 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59939976 |
52 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.54564101 |
53 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.53868601 |
54 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.49419590 |
55 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46434760 |
56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44765484 |
57 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.42947898 |
58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39976070 |
59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32807566 |
60 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.30586756 |
61 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.29311155 |
62 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.26332412 |
63 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.26034531 |
64 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.24014091 |
65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21712739 |
66 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18443093 |
67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17974532 |
68 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17911301 |
69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.14507974 |
70 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.14411480 |
71 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.12753232 |
72 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12303634 |
73 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08218053 |
74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07703512 |
75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06514866 |
76 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.06040403 |
77 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05913248 |
78 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.04056121 |
79 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02816939 |
80 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01621579 |
81 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01542837 |
82 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.01474996 |
83 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00824797 |
84 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.00159338 |
85 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00086452 |
86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97819724 |
87 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.97691479 |
88 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.97564026 |
89 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.97426546 |
90 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.95361275 |
91 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95306220 |
92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.95026251 |
93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95009499 |
94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.94719335 |
95 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.91518128 |
96 | MYC_22102868_ChIP-Seq_BL_Human | 0.90987404 |
97 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89419743 |
98 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.89089179 |
99 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.88167499 |
100 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.87164795 |
101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86489764 |
102 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.85807031 |
103 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85242582 |
104 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.84881186 |
105 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.84803587 |
106 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83853541 |
107 | P68_20966046_ChIP-Seq_HELA_Human | 0.83492118 |
108 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81630640 |
109 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.80463737 |
110 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.79754364 |
111 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.78876239 |
112 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.77900506 |
113 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.75492416 |
114 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.75261178 |
115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75137494 |
116 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.73890368 |
117 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.73669064 |
118 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.71446245 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 5.67342531 |
2 | MP0004957_abnormal_blastocyst_morpholog | 4.48253111 |
3 | MP0003111_abnormal_nucleus_morphology | 3.90755765 |
4 | MP0010094_abnormal_chromosome_stability | 3.87867232 |
5 | MP0008057_abnormal_DNA_replication | 3.82500546 |
6 | MP0003077_abnormal_cell_cycle | 3.60770119 |
7 | MP0008058_abnormal_DNA_repair | 3.58594579 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.52043542 |
9 | MP0002396_abnormal_hematopoietic_system | 3.22308289 |
10 | MP0008932_abnormal_embryonic_tissue | 3.10087593 |
11 | MP0008007_abnormal_cellular_replicative | 2.67978101 |
12 | MP0005058_abnormal_lysosome_morphology | 2.62083276 |
13 | MP0003186_abnormal_redox_activity | 2.33062077 |
14 | MP0004147_increased_porphyrin_level | 2.16031507 |
15 | MP0003786_premature_aging | 2.15465822 |
16 | MP0001730_embryonic_growth_arrest | 2.09198615 |
17 | MP0009697_abnormal_copulation | 2.01930001 |
18 | MP0009333_abnormal_splenocyte_physiolog | 2.01387900 |
19 | MP0000490_abnormal_crypts_of | 1.99017457 |
20 | MP0004233_abnormal_muscle_weight | 1.97274938 |
21 | MP0009379_abnormal_foot_pigmentation | 1.95082940 |
22 | MP0001529_abnormal_vocalization | 1.93861459 |
23 | MP0006036_abnormal_mitochondrial_physio | 1.91789716 |
24 | MP0003718_maternal_effect | 1.87114871 |
25 | MP0005451_abnormal_body_composition | 1.85920392 |
26 | MP0003656_abnormal_erythrocyte_physiolo | 1.77719537 |
27 | MP0009840_abnormal_foam_cell | 1.76465550 |
28 | MP0000350_abnormal_cell_proliferation | 1.74820102 |
29 | MP0002877_abnormal_melanocyte_morpholog | 1.73942407 |
30 | MP0003123_paternal_imprinting | 1.73106501 |
31 | MP0003191_abnormal_cellular_cholesterol | 1.66387850 |
32 | MP0001764_abnormal_homeostasis | 1.60014718 |
33 | MP0005360_urolithiasis | 1.54906432 |
34 | MP0006054_spinal_hemorrhage | 1.53897300 |
35 | MP0000678_abnormal_parathyroid_gland | 1.51296548 |
36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.51220282 |
37 | MP0005501_abnormal_skin_physiology | 1.48164310 |
38 | MP0006035_abnormal_mitochondrial_morpho | 1.41617164 |
39 | MP0000313_abnormal_cell_death | 1.36750099 |
40 | MP0001881_abnormal_mammary_gland | 1.35758271 |
41 | MP0001697_abnormal_embryo_size | 1.35756464 |
42 | MP0002080_prenatal_lethality | 1.33148191 |
43 | MP0005397_hematopoietic_system_phenotyp | 1.32672787 |
44 | MP0001545_abnormal_hematopoietic_system | 1.32672787 |
45 | MP0002796_impaired_skin_barrier | 1.31230452 |
46 | MP0000358_abnormal_cell_content/ | 1.29539640 |
47 | MP0005075_abnormal_melanosome_morpholog | 1.28127739 |
48 | MP0010352_gastrointestinal_tract_polyps | 1.27914839 |
49 | MP0002019_abnormal_tumor_incidence | 1.25478808 |
50 | MP0003763_abnormal_thymus_physiology | 1.24509622 |
51 | MP0001672_abnormal_embryogenesis/_devel | 1.19346728 |
52 | MP0005380_embryogenesis_phenotype | 1.19346728 |
53 | MP0008877_abnormal_DNA_methylation | 1.17910575 |
54 | MP0003315_abnormal_perineum_morphology | 1.16671935 |
55 | MP0002132_abnormal_respiratory_system | 1.13831446 |
56 | MP0002139_abnormal_hepatobiliary_system | 1.13363233 |
57 | MP0003984_embryonic_growth_retardation | 1.13057210 |
58 | MP0005332_abnormal_amino_acid | 1.12407324 |
59 | MP0001661_extended_life_span | 1.09297754 |
60 | MP0004133_heterotaxia | 1.08198400 |
61 | MP0002088_abnormal_embryonic_growth/wei | 1.06232703 |
62 | MP0005330_cardiomyopathy | 1.06016530 |
63 | MP0003567_abnormal_fetal_cardiomyocyte | 1.05908770 |
64 | MP0001853_heart_inflammation | 1.04780733 |
65 | MP0003221_abnormal_cardiomyocyte_apopto | 1.03488165 |
66 | MP0000689_abnormal_spleen_morphology | 1.03071200 |
67 | MP0002938_white_spotting | 1.02820872 |
68 | MP0000465_gastrointestinal_hemorrhage | 1.01235741 |
69 | MP0005266_abnormal_metabolism | 0.97630936 |
70 | MP0002085_abnormal_embryonic_tissue | 0.97108299 |
71 | MP0006292_abnormal_olfactory_placode | 0.96040841 |
72 | MP0002722_abnormal_immune_system | 0.95765668 |
73 | MP0002398_abnormal_bone_marrow | 0.94144021 |
74 | MP0002160_abnormal_reproductive_system | 0.91140427 |
75 | MP0009053_abnormal_anal_canal | 0.90414666 |
76 | MP0002060_abnormal_skin_morphology | 0.89607307 |
77 | MP0005670_abnormal_white_adipose | 0.89231508 |
78 | MP0005220_abnormal_exocrine_pancreas | 0.87015258 |
79 | MP0010030_abnormal_orbit_morphology | 0.86549701 |
80 | MP0005410_abnormal_fertilization | 0.86128911 |
81 | MP0002429_abnormal_blood_cell | 0.84098033 |
82 | MP0000703_abnormal_thymus_morphology | 0.83921839 |
83 | MP0005319_abnormal_enzyme/_coenzyme | 0.83523298 |
84 | MP0002095_abnormal_skin_pigmentation | 0.83121282 |
85 | MP0002751_abnormal_autonomic_nervous | 0.83048072 |
86 | MP0005395_other_phenotype | 0.81939145 |
87 | MP0001145_abnormal_male_reproductive | 0.81683368 |
88 | MP0002210_abnormal_sex_determination | 0.81054884 |
89 | MP0005408_hypopigmentation | 0.80922424 |
90 | MP0001293_anophthalmia | 0.78529098 |
91 | MP0005636_abnormal_mineral_homeostasis | 0.77301232 |
92 | MP0008873_increased_physiological_sensi | 0.76926691 |
93 | MP0002086_abnormal_extraembryonic_tissu | 0.76203081 |
94 | MP0001666_abnormal_nutrient_absorption | 0.76125523 |
95 | MP0001216_abnormal_epidermal_layer | 0.73677720 |
96 | MP0004185_abnormal_adipocyte_glucose | 0.73539601 |
97 | MP0001243_abnormal_dermal_layer | 0.72329737 |
98 | MP0005376_homeostasis/metabolism_phenot | 0.72180174 |
99 | MP0009278_abnormal_bone_marrow | 0.71652479 |
100 | MP0005384_cellular_phenotype | 0.71649004 |
101 | MP0005365_abnormal_bile_salt | 0.71518527 |
102 | MP0000609_abnormal_liver_physiology | 0.70574061 |
103 | MP0000749_muscle_degeneration | 0.70365097 |
104 | MP0000858_altered_metastatic_potential | 0.70161946 |
105 | MP0008260_abnormal_autophagy | 0.69849843 |
106 | MP0002084_abnormal_developmental_patter | 0.69688991 |
107 | MP0005389_reproductive_system_phenotype | 0.69312440 |
108 | MP0000627_abnormal_mammary_gland | 0.68425397 |
109 | MP0003890_abnormal_embryonic-extraembry | 0.68025802 |
110 | MP0004808_abnormal_hematopoietic_stem | 0.67781757 |
111 | MP0001873_stomach_inflammation | 0.67273237 |
112 | MP0000015_abnormal_ear_pigmentation | 0.65105832 |
113 | MP0000372_irregular_coat_pigmentation | 0.64381211 |
114 | MP0000716_abnormal_immune_system | 0.64053876 |
115 | MP0000653_abnormal_sex_gland | 0.62846091 |
116 | MP0009672_abnormal_birth_weight | 0.62108808 |
117 | MP0001119_abnormal_female_reproductive | 0.61896659 |
118 | MP0009931_abnormal_skin_appearance | 0.61677889 |
119 | MP0004197_abnormal_fetal_growth/weight/ | 0.61137844 |
120 | MP0003941_abnormal_skin_development | 0.61033826 |
121 | MP0002148_abnormal_hypersensitivity_rea | 0.60041006 |
122 | MP0004019_abnormal_vitamin_homeostasis | 0.58859009 |
123 | MP0001727_abnormal_embryo_implantation | 0.58688874 |
124 | MP0003172_abnormal_lysosome_physiology | 0.58106668 |
125 | MP0001186_pigmentation_phenotype | 0.57414901 |
126 | MP0003646_muscle_fatigue | 0.57395521 |
127 | MP0000049_abnormal_middle_ear | 0.57158365 |
128 | MP0005174_abnormal_tail_pigmentation | 0.56801461 |
129 | MP0010771_integument_phenotype | 0.56747860 |
130 | MP0004264_abnormal_extraembryonic_tissu | 0.56648722 |
131 | MP0001542_abnormal_bone_strength | 0.56042361 |
132 | MP0005464_abnormal_platelet_physiology | 0.55410647 |
133 | MP0002970_abnormal_white_adipose | 0.55286957 |
134 | MP0001905_abnormal_dopamine_level | 0.55238807 |
135 | MP0004142_abnormal_muscle_tone | 0.53839718 |
136 | MP0000598_abnormal_liver_morphology | 0.53763039 |
137 | MP0002111_abnormal_tail_morphology | 0.52788662 |
138 | MP0005621_abnormal_cell_physiology | 0.52308878 |
139 | MP0003724_increased_susceptibility_to | 0.52147798 |
140 | MP0001929_abnormal_gametogenesis | 0.51772228 |
141 | MP0010307_abnormal_tumor_latency | 0.49898234 |
142 | MP0005083_abnormal_biliary_tract | 0.49105594 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Birth length less than 3rd percentile (HP:0003561) | 4.79719191 |
2 | Abnormal number of erythroid precursors (HP:0012131) | 4.75648124 |
3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.69175526 |
4 | Carpal bone hypoplasia (HP:0001498) | 4.07266954 |
5 | Hepatocellular necrosis (HP:0001404) | 3.95799703 |
6 | Mitochondrial inheritance (HP:0001427) | 3.88667904 |
7 | Acute necrotizing encephalopathy (HP:0006965) | 3.86275802 |
8 | Cerebral hypomyelination (HP:0006808) | 3.81318764 |
9 | Hepatic necrosis (HP:0002605) | 3.79642475 |
10 | Aplastic anemia (HP:0001915) | 3.79178697 |
11 | Reticulocytopenia (HP:0001896) | 3.76609219 |
12 | Breast hypoplasia (HP:0003187) | 3.73901446 |
13 | Abnormality of glycolysis (HP:0004366) | 3.67305091 |
14 | Increased serum pyruvate (HP:0003542) | 3.67305091 |
15 | Abnormality of the anterior horn cell (HP:0006802) | 3.67293171 |
16 | Degeneration of anterior horn cells (HP:0002398) | 3.67293171 |
17 | Increased CSF lactate (HP:0002490) | 3.67184228 |
18 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.65909938 |
19 | Cholecystitis (HP:0001082) | 3.60992955 |
20 | Abnormal gallbladder physiology (HP:0012438) | 3.60992955 |
21 | Increased serum lactate (HP:0002151) | 3.59372019 |
22 | Oral leukoplakia (HP:0002745) | 3.53864840 |
23 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.49030234 |
24 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.49030234 |
25 | Acute encephalopathy (HP:0006846) | 3.31098845 |
26 | Microretrognathia (HP:0000308) | 3.17926953 |
27 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.10627482 |
28 | Macrocytic anemia (HP:0001972) | 3.10103838 |
29 | Rough bone trabeculation (HP:0100670) | 2.97748660 |
30 | Increased hepatocellular lipid droplets (HP:0006565) | 2.89629375 |
31 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.85129732 |
32 | 3-Methylglutaconic aciduria (HP:0003535) | 2.83424302 |
33 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.81708909 |
34 | Lactic acidosis (HP:0003128) | 2.80935220 |
35 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.78396789 |
36 | Progressive macrocephaly (HP:0004481) | 2.77722731 |
37 | Exercise intolerance (HP:0003546) | 2.66458018 |
38 | Respiratory failure (HP:0002878) | 2.62775244 |
39 | Pallor (HP:0000980) | 2.62481814 |
40 | Progressive muscle weakness (HP:0003323) | 2.62417655 |
41 | Patellar aplasia (HP:0006443) | 2.60088259 |
42 | Lipid accumulation in hepatocytes (HP:0006561) | 2.58467962 |
43 | Pancytopenia (HP:0001876) | 2.58079094 |
44 | CNS demyelination (HP:0007305) | 2.56696823 |
45 | Exertional dyspnea (HP:0002875) | 2.55118313 |
46 | Spastic paraparesis (HP:0002313) | 2.52836363 |
47 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.52786926 |
48 | Testicular atrophy (HP:0000029) | 2.51560371 |
49 | * Type I transferrin isoform profile (HP:0003642) | 2.49840146 |
50 | Lethargy (HP:0001254) | 2.42719909 |
51 | CNS hypomyelination (HP:0003429) | 2.40307028 |
52 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.39111538 |
53 | Irregular epiphyses (HP:0010582) | 2.38860258 |
54 | Multiple enchondromatosis (HP:0005701) | 2.37120264 |
55 | Hyperammonemia (HP:0001987) | 2.36981813 |
56 | Selective tooth agenesis (HP:0001592) | 2.35189702 |
57 | Hypokinesia (HP:0002375) | 2.34768817 |
58 | Renal Fanconi syndrome (HP:0001994) | 2.33731361 |
59 | Premature graying of hair (HP:0002216) | 2.32713613 |
60 | Colon cancer (HP:0003003) | 2.31029854 |
61 | Cerebral edema (HP:0002181) | 2.30413071 |
62 | Seborrheic dermatitis (HP:0001051) | 2.29269302 |
63 | Reduced antithrombin III activity (HP:0001976) | 2.26706161 |
64 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.25751100 |
65 | Increased intramyocellular lipid droplets (HP:0012240) | 2.23971970 |
66 | Emotional lability (HP:0000712) | 2.23694397 |
67 | Nausea (HP:0002018) | 2.23327035 |
68 | Hyperalaninemia (HP:0003348) | 2.23038426 |
69 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.23038426 |
70 | Abnormality of alanine metabolism (HP:0010916) | 2.23038426 |
71 | Hypoplastic pelvis (HP:0008839) | 2.21663355 |
72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.19507694 |
73 | Dicarboxylic aciduria (HP:0003215) | 2.19507694 |
74 | Vertebral compression fractures (HP:0002953) | 2.16104038 |
75 | Abnormality of methionine metabolism (HP:0010901) | 2.15719933 |
76 | Sparse eyelashes (HP:0000653) | 2.13746020 |
77 | Respiratory difficulties (HP:0002880) | 2.11235570 |
78 | Ragged-red muscle fibers (HP:0003200) | 2.10863922 |
79 | Microvesicular hepatic steatosis (HP:0001414) | 2.10788404 |
80 | Poor head control (HP:0002421) | 2.10062604 |
81 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.06938355 |
82 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.06078607 |
83 | 11 pairs of ribs (HP:0000878) | 2.05685027 |
84 | Megaloblastic anemia (HP:0001889) | 2.04348278 |
85 | Achilles tendon contracture (HP:0001771) | 2.03817370 |
86 | Abnormal trabecular bone morphology (HP:0100671) | 2.02223792 |
87 | Bone marrow hypocellularity (HP:0005528) | 2.02018136 |
88 | Horseshoe kidney (HP:0000085) | 2.00601957 |
89 | Tongue fasciculations (HP:0001308) | 1.99714664 |
90 | Thrombocytosis (HP:0001894) | 1.99119639 |
91 | Generalized aminoaciduria (HP:0002909) | 1.99017132 |
92 | Progressive microcephaly (HP:0000253) | 1.98780110 |
93 | Chromsome breakage (HP:0040012) | 1.96732472 |
94 | Opisthotonus (HP:0002179) | 1.96696900 |
95 | * Abnormal protein glycosylation (HP:0012346) | 1.96100307 |
96 | * Abnormal glycosylation (HP:0012345) | 1.96100307 |
97 | * Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.96100307 |
98 | * Abnormal protein N-linked glycosylation (HP:0012347) | 1.96100307 |
99 | Cellular immunodeficiency (HP:0005374) | 1.95426148 |
100 | Postnatal microcephaly (HP:0005484) | 1.95309395 |
101 | Absent thumb (HP:0009777) | 1.94999793 |
102 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.94114818 |
103 | Abnormality of the umbilical cord (HP:0010881) | 1.93746546 |
104 | Abnormality of the Achilles tendon (HP:0005109) | 1.91985486 |
105 | Secondary amenorrhea (HP:0000869) | 1.91222024 |
106 | Premature ovarian failure (HP:0008209) | 1.90936404 |
107 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.90776338 |
108 | Trismus (HP:0000211) | 1.90397977 |
109 | Abnormality of the pons (HP:0007361) | 1.90153706 |
110 | Type 2 muscle fiber atrophy (HP:0003554) | 1.88105348 |
111 | Absent radius (HP:0003974) | 1.88014173 |
112 | Abnormality of the preputium (HP:0100587) | 1.86778336 |
113 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.86042040 |
114 | Nonimmune hydrops fetalis (HP:0001790) | 1.85731363 |
115 | Upper limb muscle weakness (HP:0003484) | 1.85292802 |
116 | Increased muscle lipid content (HP:0009058) | 1.85231051 |
117 | Death in infancy (HP:0001522) | 1.84753470 |
118 | Hypoplasia of the pons (HP:0012110) | 1.84712077 |
119 | Abnormality of serum amino acid levels (HP:0003112) | 1.84486216 |
120 | Leukodystrophy (HP:0002415) | 1.84388436 |
121 | Unsteady gait (HP:0002317) | 1.84039080 |
122 | Abnormal number of incisors (HP:0011064) | 1.83287953 |
123 | Hypertensive crisis (HP:0100735) | 1.82897345 |
124 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.82448971 |
125 | Muscle fiber atrophy (HP:0100295) | 1.82173731 |
126 | Absent epiphyses (HP:0010577) | 1.81263881 |
127 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.81263881 |
128 | Cholelithiasis (HP:0001081) | 1.80395128 |
129 | Cleft eyelid (HP:0000625) | 1.75074567 |
130 | Abnormality of reticulocytes (HP:0004312) | 1.73742667 |
131 | Hypergonadotropic hypogonadism (HP:0000815) | 1.73103907 |
132 | Abnormal pupillary function (HP:0007686) | 1.72368615 |
133 | Methylmalonic aciduria (HP:0012120) | 1.70268755 |
134 | Patchy hypopigmentation of hair (HP:0011365) | 1.67681876 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BUB1 | 4.74076945 |
2 | VRK2 | 4.45486508 |
3 | EIF2AK1 | 3.83596280 |
4 | WEE1 | 3.82080080 |
5 | STK16 | 3.59475286 |
6 | EIF2AK3 | 3.03247633 |
7 | NME2 | 3.03222401 |
8 | SRPK1 | 2.89283263 |
9 | TSSK6 | 2.77195405 |
10 | CDC7 | 2.75376237 |
11 | VRK1 | 2.74151562 |
12 | PIM2 | 2.40628887 |
13 | TESK2 | 2.20443619 |
14 | PDK2 | 2.01399489 |
15 | NEK1 | 1.87088583 |
16 | PLK4 | 1.85461174 |
17 | SMG1 | 1.71749439 |
18 | BCKDK | 1.71678264 |
19 | MKNK1 | 1.68101556 |
20 | TAF1 | 1.63178554 |
21 | SCYL2 | 1.63158274 |
22 | BRSK2 | 1.61069801 |
23 | MST1R | 1.59727524 |
24 | CDK7 | 1.53495394 |
25 | TLK1 | 1.44020844 |
26 | PLK1 | 1.43892516 |
27 | CDK8 | 1.43432300 |
28 | ATR | 1.33909344 |
29 | KDR | 1.32770123 |
30 | AURKA | 1.29533897 |
31 | RPS6KA4 | 1.29445230 |
32 | CCNB1 | 1.28844272 |
33 | TTK | 1.26736299 |
34 | NME1 | 1.25806755 |
35 | BRSK1 | 1.22411945 |
36 | MAP3K11 | 1.21142605 |
37 | PASK | 1.20521177 |
38 | PLK3 | 1.19943348 |
39 | AURKB | 1.19603645 |
40 | NEK2 | 1.16132532 |
41 | DYRK3 | 1.15224641 |
42 | MAP3K12 | 1.14358843 |
43 | RPS6KB2 | 1.13964818 |
44 | MKNK2 | 1.11701961 |
45 | MAP4K1 | 1.04602436 |
46 | ACVR1B | 1.03102034 |
47 | ZAK | 1.02578061 |
48 | EIF2AK2 | 0.99524466 |
49 | STK10 | 0.97532070 |
50 | BRAF | 0.97062945 |
51 | MAP3K8 | 0.91243989 |
52 | IRAK4 | 0.90006002 |
53 | NUAK1 | 0.88477808 |
54 | IRAK3 | 0.88387374 |
55 | PTK2 | 0.86752533 |
56 | CSNK2A1 | 0.85785217 |
57 | PAK4 | 0.81727281 |
58 | TESK1 | 0.81680458 |
59 | KIT | 0.77841765 |
60 | CHEK2 | 0.76621352 |
61 | TRIM28 | 0.76507849 |
62 | ABL2 | 0.76404769 |
63 | ILK | 0.75608094 |
64 | CSNK2A2 | 0.75066370 |
65 | PIM1 | 0.73450859 |
66 | PBK | 0.72795222 |
67 | PAK1 | 0.71616817 |
68 | LIMK1 | 0.69809497 |
69 | MET | 0.69227800 |
70 | MAP2K3 | 0.67294626 |
71 | ICK | 0.66814950 |
72 | MAPKAPK5 | 0.66805702 |
73 | LRRK2 | 0.66474771 |
74 | MAPKAPK3 | 0.64883896 |
75 | CSNK1G3 | 0.64531699 |
76 | TEC | 0.64211354 |
77 | MST4 | 0.64030754 |
78 | CHEK1 | 0.63899803 |
79 | MAP4K2 | 0.62756993 |
80 | SIK3 | 0.61708108 |
81 | ERN1 | 0.61619744 |
82 | EPHA2 | 0.61340740 |
83 | CLK1 | 0.61222438 |
84 | CDK4 | 0.59035692 |
85 | DYRK2 | 0.57833776 |
86 | CDK19 | 0.57702450 |
87 | RPS6KA5 | 0.57236047 |
88 | BTK | 0.57095721 |
89 | ERBB4 | 0.56800595 |
90 | MYLK | 0.54496242 |
91 | STK4 | 0.54275022 |
92 | MAP3K3 | 0.53427391 |
93 | CDK2 | 0.47553309 |
94 | ATM | 0.47344016 |
95 | RPS6KA6 | 0.45285137 |
96 | AKT3 | 0.43232002 |
97 | FLT3 | 0.42356138 |
98 | MARK3 | 0.42194559 |
99 | OBSCN | 0.41556297 |
100 | LMTK2 | 0.40762290 |
101 | ZAP70 | 0.40655338 |
102 | TAOK2 | 0.39935752 |
103 | PRKCI | 0.39799198 |
104 | TXK | 0.39009373 |
105 | CDK9 | 0.38742283 |
106 | MAPK11 | 0.37659553 |
107 | TBK1 | 0.37125324 |
108 | MAPKAPK2 | 0.36411904 |
109 | AKT2 | 0.35547839 |
110 | BLK | 0.34892690 |
111 | CDK1 | 0.34311568 |
112 | RPS6KC1 | 0.34132293 |
113 | RPS6KL1 | 0.34132293 |
114 | LYN | 0.31783176 |
115 | DAPK3 | 0.31574694 |
116 | PNCK | 0.31066847 |
117 | ARAF | 0.30592495 |
118 | CSNK1A1L | 0.30162876 |
119 | IRAK1 | 0.28686907 |
120 | BRD4 | 0.28377023 |
121 | MAPK15 | 0.28111234 |
122 | DAPK1 | 0.27756913 |
123 | MUSK | 0.27598825 |
124 | IKBKB | 0.27180278 |
125 | YES1 | 0.26743035 |
126 | CSNK1G1 | 0.26617902 |
127 | MAP3K6 | 0.25417964 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 4.49391671 |
2 | Proteasome_Homo sapiens_hsa03050 | 4.36428152 |
3 | Ribosome_Homo sapiens_hsa03010 | 4.06212364 |
4 | RNA polymerase_Homo sapiens_hsa03020 | 3.74311903 |
5 | Mismatch repair_Homo sapiens_hsa03430 | 3.54655045 |
6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.28187636 |
7 | Base excision repair_Homo sapiens_hsa03410 | 2.85614403 |
8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.79755012 |
9 | Spliceosome_Homo sapiens_hsa03040 | 2.72529741 |
10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.60464403 |
11 | Homologous recombination_Homo sapiens_hsa03440 | 2.52094879 |
12 | RNA transport_Homo sapiens_hsa03013 | 2.42527263 |
13 | Protein export_Homo sapiens_hsa03060 | 2.39501209 |
14 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.27758156 |
15 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.17868721 |
16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.06881580 |
17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.93287757 |
18 | Cell cycle_Homo sapiens_hsa04110 | 1.77126106 |
19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.73461174 |
20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.55819626 |
21 | Purine metabolism_Homo sapiens_hsa00230 | 1.53260574 |
22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49644356 |
23 | Basal transcription factors_Homo sapiens_hsa03022 | 1.45662065 |
24 | RNA degradation_Homo sapiens_hsa03018 | 1.45053497 |
25 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.44646047 |
26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42018540 |
27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33167384 |
28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30622822 |
29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.30173979 |
30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.29929831 |
31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19441633 |
32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.11604467 |
33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11311096 |
34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10457777 |
35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.09461628 |
36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.06581539 |
37 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.06377076 |
38 | Alzheimers disease_Homo sapiens_hsa05010 | 1.05432667 |
39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05016141 |
40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.01892896 |
41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97734200 |
42 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.95045199 |
43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94014937 |
44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90392600 |
45 | * N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.90111524 |
46 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89202414 |
47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.81669901 |
48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.80696429 |
49 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.78943717 |
50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75511945 |
51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75228511 |
52 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.69659016 |
53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68544962 |
54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66676827 |
55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.64018111 |
56 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60560772 |
57 | Legionellosis_Homo sapiens_hsa05134 | 0.60351023 |
58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58485679 |
59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55673135 |
60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55366392 |
61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.52345986 |
62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51957105 |
63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51707086 |
64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50969761 |
65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50727221 |
66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49722124 |
67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47983348 |
68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47900926 |
69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47816891 |
70 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47759199 |
71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46897898 |
72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46363581 |
73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44961832 |
74 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40598462 |
75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37045538 |
76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36844649 |
77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.33909411 |
78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.33094467 |
79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31502215 |
80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.27662492 |
81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26589651 |
82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24726802 |
83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.24331425 |
84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23288313 |
85 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.23190196 |
86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.23109256 |
87 | Lysosome_Homo sapiens_hsa04142 | 0.22048825 |
88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20215019 |
89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20101357 |
90 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.19389272 |
91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.18819548 |
92 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.17029266 |
93 | Peroxisome_Homo sapiens_hsa04146 | 0.16875048 |
94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.16578123 |
95 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.16542651 |
96 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.15855937 |
97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.15044413 |
98 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.14510995 |
99 | Bladder cancer_Homo sapiens_hsa05219 | 0.14401462 |
100 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.14380052 |
101 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.14292605 |
102 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.14274309 |
103 | Shigellosis_Homo sapiens_hsa05131 | 0.14264443 |
104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13727966 |
105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.12729093 |
106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.12466980 |
107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.12077534 |
108 | Asthma_Homo sapiens_hsa05310 | 0.11687822 |
109 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.10469557 |
110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.08331321 |
111 | Apoptosis_Homo sapiens_hsa04210 | 0.07882983 |
112 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.07518189 |
113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.06433777 |
114 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.06294062 |
115 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.05790197 |
116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.04915162 |
117 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.04441552 |